{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:52:07Z","timestamp":1792266727715,"version":"4.4.0"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jdcr.2026.06.061","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:22:18Z","timestamp":1783120938000},"page":"41-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Papulovesicular eruption after administration of zoledronic acid: A rare cutaneous manifestation of an acute phase reaction"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1733-4229","authenticated-orcid":false,"given":"ShengYang Bertrand","family":"Lian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Weiting","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee Kiat","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jdcr.2026.06.061_bib1","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1210\/jc.2010-0597","article-title":"Characterization of and risk factors for the acute-phase response after zoledronic acid","volume":"95","author":"Reid","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jdcr.2026.06.061_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40261-012-0041-1","article-title":"Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice","volume":"33","author":"Sieber","year":"2013","journal-title":"Clin Drug Investig"},{"issue":"6","key":"10.1016\/j.jdcr.2026.06.061_bib4","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00223-021-00884-7","article-title":"Acute phase reactions after intravenous infusion of zoledronic acid in Japanese patients with osteoporosis: sub-analyses of the Phase III ZONE study","volume":"109","author":"Shiraki","year":"2021","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"10.1016\/j.jdcr.2026.06.061_bib5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1359\/JBMR.0301230","article-title":"Statins prevent bisphosphonate-induced \u03b3,\u03b4-T-cell proliferation and activation in vitro","volume":"19","author":"Thompson","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"11","key":"10.1016\/j.jdcr.2026.06.061_bib6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/107999003322558782","article-title":"Fever after zoledronic acid administration is due to increase in TNF-\u03b1 and IL-6","volume":"23","author":"Dicuonzo","year":"2003","journal-title":"J Interferon Cytokine Res"},{"issue":"1","key":"10.1016\/j.jdcr.2026.06.061_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12865-016-0183-7","article-title":"Immune modulation of CD4+CD25+ regulatory T cells by Zoledronic acid","volume":"17","author":"Liu","year":"2016","journal-title":"BMC Immunol"},{"key":"10.1016\/j.jdcr.2026.06.061_bib8","article-title":"Advancing the understanding of allergic contact dermatitis: from pathophysiology to novel therapeutic approaches","volume":"10","author":"Tramontana","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"10.1016\/j.jdcr.2026.06.061_bib9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00774-019-01050-8","article-title":"Efficacy of non-steroidal anti-inflammatory drugs on zoledronic acid-induced acute-phase reactions: randomized, open-label, Japanese OZ study","volume":"38","author":"Okimoto","year":"2020","journal-title":"J Bone Miner Metab"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626004091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626004091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:39:17Z","timestamp":1792265957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512626004091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":8,"alternative-id":["S2352512626004091"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.06.061","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Papulovesicular eruption after administration of zoledronic acid: A rare cutaneous manifestation of an acute phase reaction","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.06.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}